Evidence map›Paper›PMID 35118257›Full record

ReviewMediastinum (Hong Kong, China)2019

Determining extent of invasion and follow-up of thymic epithelial malignancies.

Marcelo F Benveniste, Sonia L Betancourt Cuellar, Brett W Carter, Girish S Shroff, Carol Wu, Edith M Marom

Open access · diamondAbstract readReview
In one paragraph

Review in Mediastinum (Hong Kong, China), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marcelo F BenvenisteDepartment of Diagnostic Radiology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Sonia L Betancourt CuellarDepartment of Diagnostic Radiology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Brett W CarterDepartment of Diagnostic Radiology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Girish S ShroffDepartment of Diagnostic Radiology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Carol WuDepartment of Diagnostic Radiology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Edith M MaromDepartment of Diagnostic Imaging, The Chaim Sheba Medical Center, Ramat Gan, Israel affiliated with the Tel Aviv University, Tel Aviv, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymic malignancies may exhibit aggressive behavior such as invasion of adjacent structures and involvement of the pleura and pericardium. The role of imaging in the evaluation of primary thymic neoplasms is to properly assess tumor staging, with emphasis on the detection of local invasion and distant spread of disease, correctly identifying candidates for preoperative neoadjuvant therapy. Different imaging modalities are used in the initial investigation of thymic malignancies including chest radiography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET), in particular with [18F] fluorodeoxyglucose (FDG). At this moment, CT is the most common imaging modality on the assessment of thymic malignancies. MRI has the benefit of no emission of damaging ionizing radiation reducing the radiation dose to the patient when compared with CT. For this reason, MRI has been playing an important role in the evaluation of tumor invasion and follow up imaging studies which becomes even more relevant in young patients or those patients with prior history of radiation therapy.

Indexed as

computed tomography (CT)magnetic resonance imaging (MRI)Thymic malignancy

Identifiers

PMID35118257
PMCPMC8794300
OpenAlexW2963674461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.